1 |
Ferrero-Miliani, L., Nielsen, O. H., Andersen, P. S. and Girardin, S. E. : Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin. Exp. Immunol. 147, 227 (2007).
|
2 |
Kaur, M., Singh, M. and Silakari, O. : Inhibitors of switch kinase 'spleen tyrosine kinase' in inflammation and immunemediated disorders: a review. Eur. J. Med. Chem. 67, 434 (2013).
DOI
|
3 |
Massarotti, E. M. : Clinical and patient-reported outcomes in clinical trials of abatacept in the treatment of rheumatoid arthritis. Clin. Ther. 30, 429 (2008).
DOI
|
4 |
Taylor, P. R., Martinez-Pomares, L., Stacey, M., Lin, H. H., Brown, G. D. and Gordon, S. : Macrophage receptors and immune recognition. Annu. Rev. Immunol. 23, 901 (2005).
DOI
|
5 |
Vo, V. A., Lee, J. W., Chang, J. E., Kim, J. Y., Kim, N. H., Lee, H. J., Kim, S. S., Chun, W. and Kwon, Y. S. : Avicularin inhibits lipopolysaccharide-induced inflammatory response by suppressing ERK phosphorylation in RAW 264.7 macrophages. Biomol. Ther. (Seoul) 20, 532 (2012).
DOI
|
6 |
Yi, Y. S., Son, Y. J., Ryou, C., Sung, G. H., Kim, J. H. and Cho, J. Y. : Functional roles of Syk in macrophage-mediated inflammatory responses. Mediators Inflamm. 2014, 270302 (2014).
|
7 |
Yang, Y., Kim, S. C., Yu, T., Yi, Y. S., Rhee, M. H., Sung, G. H., Yoo, B. C. and Cho, J. Y. : Functional roles of p38 mitogenactivated protein kinase in macrophage-mediated inflammatory responses. Mediators Inflamm. 2014, 352371 (2014).
|
8 |
Byeon, S. E., Yi, Y. S., Oh, J., Yoo, B. C., Hong, S. and Cho, J. Y. : The role of Src kinase in macrophage-mediated inflammatory responses. Mediators Inflamm. 2012, 512926 (2012).
|
9 |
Yu, T., Yi, Y. S., Yang, Y., Oh, J., Jeong, D. and Cho, J. Y. : The pivotal role of TBK1 in inflammatory responses mediated by macrophages. Mediators Inflamm. 2012, 979105 (2012).
|
10 |
Rathjen, F. G. and Schachner, M. : Immunocytological and biochemical characterization of a new neuronal cell surface component (L1 antigen) which is involved in cell adhesion. EMBO J. 3, 1 (1984).
|
11 |
Brummendorf, T. and Rathjen, F. G. : Cell adhesion molecules 1: immunoglobulin superfamily. Protein Profile 2, 963 (1995).
|
12 |
Weichert, W., Knosel, T., Bellach, J., Dietel, M. and Kristiansen, G. : ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J. Clin. Pathol. 57, 1160 (2004).
DOI
|
13 |
Siesser, P. F. and Maness, P. F. : L1 cell adhesion molecules as regulators of tumor cell invasiveness. Cell. Adh. Migr. 3, 275 (2009).
DOI
|
14 |
Zecchini, S. and Cavallaro, U. : Neural cell adhesion molecule in cancer: expression and mechanisms. Adv. Exp. Med. Biol. 663, 319 (2010).
|
15 |
Bergom, C., Gao, C. and Newman, P. J. : Mechanisms of PECAM-1-mediated cytoprotection and implications for cancer cell survival. Leuk. Lymphoma 46, 1409 (2005).
DOI
|
16 |
Choi, S. Y., Jo, Y. S., Huang, S. M., Liang, Z. L., Min, J. K., Hong, H. J. and Kim, J. M. : L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma. Hum. Pathol. 42, 1476 (2011).
DOI
|
17 |
Li, S., Jo, Y. S., Lee, J. H., Min, J. K., Lee, E. S., Park, T., Kim, J. M. and Hong, H. J. : L1 cell adhesion molecule is a novel independent poor prognostic factor of extrahepatic cholangiocarcinoma. Clin. Cancer Res. 15, 7345 (2009).
DOI
|
18 |
Raveh, S., Gavert, N. and Ben-Ze'ev, A. : L1 cell adhesion molecule (L1CAM) in invasive tumors. Cancer Lett. 282, 137 (2009).
DOI
|
19 |
Gast, D., Riedle, S., Schabath, H., Schlich, S., Schneider, A., Issa, Y., Stoeck, A., Fogel, M., Joumaa, S., Wenger, T., Herr, I., Gutwein, P. and Altevogt, P. : L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas. Int. J. Cancer 115, 658 (2005).
DOI
|
20 |
Gavert, N., Conacci-Sorrell, M., Gast, D., Schneider, A., Altevogt, P., Brabletz, T. and Ben-Ze'ev, A. : L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J. Cell. Biol. 168, 633 (2005).
DOI
|
21 |
Min, J. K., Kim, J. M., Li, S., Lee, J. W., Yoon, H., Ryu, C. J., Jeon, S. H., Lee, J. H., Kim, J. Y., Yoon, H. K., Lee, Y. K., Kim, B. H., Son, Y. S., Choi, H. S., Lim, N. K., Kim, D. G. and Hong, H. J. : L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma. Clin. Cancer Res. 16, 3571 (2010).
DOI
|
22 |
Silletti, S., Mei, F., Sheppard, D. and Montgomery, A. M. : Plasmin-sensitive dibasic sequences in the third fibronectinlike domain of L1-cell adhesion molecule (CAM) facilitate homomultimerization and concomitant integrin recruitment. J. Cell. Biol. 149, 1485 (2000).
DOI
|
23 |
Jeong, D., Yi, Y. S., Sung, G. H., Yang, W. S., Park, J. G., Yoon, K., Yoon, D. H., Song, C., Lee, Y., Rhee, M. H., Kim, T. W., Kim, J. H. and Cho, J. Y. : Anti-inflammatory activities and mechanisms of Artemisia asiatica ethanol extract. J. Ethnopharmacol. 152, 487 (2014).
DOI
|
24 |
Dung, T. T., Yi, Y. S., Heo, J., Yang, W. S., Kim, J. H., Kim, H. G., Park, J. G., Yoo, B. C., Cho, J. Y. and Hong, S. : Critical role of protein L-isoaspartyl methyltransferase in basic fibroblast growth factor-mediated neuronal cell differentiation. BMB Rep. (2016).
|
25 |
Yang, W. S., Jeong, D., Yi, Y. S., Park, J. G., Seo, H., Moh, S. H., Hong, S. and Cho, J. Y. : IRAK1/4-targeted anti-inflammatory action of caffeic acid. Mediators Inflamm. 2013, 518183 (2013).
|
26 |
Yi, Y. S., Baek, K. S. and Cho, J. Y. : L1 cell adhesion molecule induces melanoma cell motility by activation of mitogenactivated protein kinase pathways. Pharmazie 69, 461 (2014).
|
27 |
Ben, Q., An, W., Fei, J., Xu, M., Li, G., Li, Z. and Yuan, Y. : Downregulation of L1CAM inhibits proliferation, invasion and arrests cell cycle progression in pancreatic cancer cells. Exp. Ther. Med. 7, 785 (2014).
DOI
|
28 |
Jung, J., Son, Y. S., Park, H., Jeon, S. K., Lee, J. W., Choi, S. Y., Kim, J. M., Kwon, Y. G., Hong, H. J. and Min, J. K. : The cell adhesion molecule L1 promotes gallbladder carcinoma progression in vitro and in vivo. Oncol. Rep. 25, 945 (2011).
|
29 |
Kim, H. S., Yi, S. Y., Jun, H. J., Ahn, J. S., Ahn, M. J., Lee, J., Kim, Y., Cui, Z. Y., Hong, H. J., Kim, J. M., Li, S., Hwang, I. G. and Park, K. : L1 cell adhesion molecule as a predictor for recurrence in pulmonary carcinoids and large-cell neuroendocrine tumors. APMIS 117, 140 (2009).
DOI
|
30 |
Doberstein, K., Milde-Langosch, K., Bretz, N. P., Schirmer, U., Harari, A., Witzel, I., Ben-Arie, A., Hubalek, M., Muller-Holzner, E., Reinold, S., Zeimet, A. G., Altevogt, P. and Fogel, M. : L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptor. BMC Cancer 14, 958 (2014).
DOI
|
31 |
Yoon, H., Min, J. K., Lee, D. G., Kim, D. G., Koh, S. S. and Hong, H. J. : L1 cell adhesion molecule and epidermal growth factor receptor activation confer cisplatin resistance in intrahepatic cholangiocarcinoma cells. Cancer Lett. 316, 70 (2012).
DOI
|
32 |
Son, Y. S., Seong, R. H., Ryu, C. J., Cho, Y. S., Bae, K. H., Chung, S. J., Lee, B., Min, J. K. and Hong, H. J. : Brief report: L1 cell adhesion molecule, a novel surface molecule of human embryonic stem cells, is essential for self-renewal and pluripotency. Stem Cells 29, 2094 (2011).
DOI
|
33 |
Anderson, H. J. and Galileo, D. S. : Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAMstimulated glioblastoma cell motility and proliferation. Cell Oncol. (Dordr) (2016).
|
34 |
Shtutman, M., Levina, E., Ohouo, P., Baig, M. and Roninson, I. B. : Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells. Cancer Res. 66, 11370 (2006).
DOI
|